Fundamentally low reproducibility in molecular genetic cancer research


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The review discusses the causes of multiple failures in cancer treatment, which might primarily result from the excessive variability of cancer genomes. They are capable of changing their spatial and temporal architecture during tumor development. The key reasons of irreproducibility of biomedical data and the presumable means for improvement of therapeutic results aiming at targeting the most stable tumor traits are suggested.

About the authors

I. V. Alekseenko

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Author for correspondence.
Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

V. V. Pleshkan

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

G. S. Monastyrskaya

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

A. I. Kuzmich

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

E. V. Snezhkov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

D. A. Didych

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

E. D. Sverdlov

Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

Email: irina.alekseenko@mail.ru
Russian Federation, Moscow, 117997

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Pleiades Publishing, Inc.